Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04040348 · ClinicalTrials.gov registry record · Phase 1

Alzheimer's Disease Stem Cells Multiple Infusions

A Phase 1 study of Alzheimer Disease, sponsored by Bernard (Barry) Baumel.

Completed
Registry status
Phase 1
Development phase
6
Enrollment target
1
Study location

NCT04040348: Completed Phase 1 study of Alzheimer Disease, sponsored by Bernard (Barry) Baumel.

NCT04040348 is a Phase 1 study of Alzheimer Disease that has completed, run by Bernard (Barry) Baumel. The registered enrollment target is 6 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04040348, a Phase 1 study of Alzheimer Disease, has completed, sponsored by Bernard (Barry) Baumel.

COMPLETED
Registry status
Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

Primary Outcome

All adverse events will be evaluated by the investigator for relationship with the study intervention. Treatment-Emergent Serious Adverse Events is defined as any untoward medical occurrence with a reasonable possibility that it is caused by the study intervention that: * Is life-threatening (e.g.; leads to stroke or non-fatal pulmonary embolism); * Requires inpatient hospitalization or prolongation of existing hospitalization; * Results in persistent or significant disability/incapacity * Resu

Conditions Studied

Alzheimer Disease

Interventions

  • BIOLOGICAL Approximately 100 million cells allogeneic hMSC

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-10-08
Est. Completion 2023-04-25
Phase Phase 1
Bernard (Barry) Baumel

3 total trials

What the finished NCT04040348 record still lists

NCT04040348 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Approximately 100 million cells allogeneic hMSC is the first listed.

NCT04040348 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04040348 about?

NCT04040348 is a clinical study titled "Alzheimer's Disease Stem Cells Multiple Infusions". The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

What is the current status of trial NCT04040348?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-10-08. Estimated completion is 2023-04-25.

What conditions does trial NCT04040348 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT04040348?

The interventions under investigation include: Approximately 100 million cells allogeneic hMSC (BIOLOGICAL).

Who is sponsoring clinical trial NCT04040348?

This trial is sponsored by Bernard (Barry) Baumel, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04040348 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04040348's enrollment target sits among peer trials

6 300th of 306 higher than 5 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04040348, the US trial registry maintained by the National Library of Medicine. NCT04040348 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.